Operator-Dependent Results Cloud Picture in FDA 2002 Approval of Medtronic, Inc. (MDT)'s BMP-2
12/29/2010 1:21:31 PM
MedPage Today -- One of the more controversial aspects of the FDA's 2002 approval of bone morphogenetic protein-2 or BMP-2, is the relationship between financial ties to Medtronic, the maker of BMP-2, and the procedural success rate of surgeons. That fact was noted in FDA documents labeled "confidential" that were obtained by MedPage Today and the Milwaukee Journal Sentinel under a Freedom of Information Act request.
comments powered by